ATRA stock

Atara Biotherapeutics Inc (ATRA) financials · rev $1.1M

Atara Biotherapeutics Inc (ATRA) rev $1.1M.

Cached annual income statement
LineFY2025FY2024
Revenue$120.8M$128.9M
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income$35.9M-$83.4M
Net Income$32.7M-$85.4M
EPS (Diluted)$2.57$-11.41
Cached annual balance sheet
LineFY2025FY2024
Total Assets$20.2M$109.1M
Current Assets$12.2M$64.9M
Cash & Equivalents$8.5M$25.0M
Inventory$0$10.7M
PP&E$73.0K$1.3M
Total Liabilities$58.7M$206.4M
Current Liabilities$14.9M$134.6M
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$38.5M-$97.3M
Retained Earnings-$2.02B-$2.05B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$50.9M-$68.7M
CapEx$0$246.0K
Investing Cash Flow$18.1M$8.6M
Financing Cash Flow$16.1M$59.3M
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow-$50.9M-$69.0M

FAQ

What is ATRA P/E and revenue?

Atara Biotherapeutics Inc (ATRA) rev $1.1M.

What is ATRA revenue?

Atara Biotherapeutics Inc last cached revenue is $120.8M (FY2025).

Is ATRA profitable?

Atara Biotherapeutics Inc last cached net income is $32.7M.

What are ATRA total assets?

Atara Biotherapeutics Inc last cached total assets are $20.2M.

What is ATRA free cash flow?

Atara Biotherapeutics Inc last cached free cash flow is -$50.9M.

Not investment advice. Cached statements, not a live tape.